This is the authors' abstract. We don't add key points for this paper.
-DCFDA and JC-1 biochemical staining confirmed a substantial increase in the reactive oxygen species generation and mitochondrial damage in PNNO NP-treated A549 cancer cells, respectively. AO/EtBr staining and flow cytometry analysis indicated that A549 cancer cells subjected to PNNO NPs underwent apoptosis, and this was strongly supported by the downregulation of the mRNA expression of the antiapoptotic gene BCL2. Collectively, these compelling results highlight the substantial therapeutic potential of PNNO NPs as an effective agent for combating lung cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Panneerselvam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: